Table 1.
Unadjusted associations of patient characteristics with an osteoporosis medication or antiresorptive agent.
| Variable | Osteoporosis medication |
Antiresorptive agent |
||||||
|---|---|---|---|---|---|---|---|---|
| Total (n = 5660) | P-value | Females (n = 4868) | P-value | Total (n = 5660) | P-value | Females (n = 4868) | P-value | |
| Continuous variablea | ||||||||
| Age | 0.294 | <0.0001 | 0.340 | <0.0001 | 0.266 | <0.0001 | 0.302 | <0.0001 |
| Body mass index | −0.100 | <0.0001 | −0.0582 | <0.0001 | −0.0797 | <0.0001 | −0.0485 | 0.00079 |
| Duration of RA | 0.259 | <0.0001 | 0.274 | <0.0001 | 0.199 | <0.0001 | 0.209 | <0.0001 |
| DAS28 | 0.181 | <0.0001 | 0.160 | <0.0001 | 0.150 | <0.0001 | 0.139 | <0.0001 |
| JHAQ-DI | 0.280 | <0.0001 | 0.271 | <0.0001 | 0.217 | <0.0001 | 0.210 | <0.0001 |
| ESR | 0.163 | <0.0001 | 0.143 | <0.0001 | 0.141 | <0.0001 | 0.131 | <0.0001 |
| CRP | 0.0782 | <0.0001 | 0.0976 | <0.0001 | 0.0627 | <0.0001 | 0.0794 | <0.0001 |
| MTX dose | −0.0155 | 0.306 | −0.0139 | 0.394 | −0.0211 | 0.163 | −0.0186 | 0.255 |
| PSL dose | 0.278 | <0.0001 | 0.276 | <0.0001 | 0.229 | <0.0001 | 0.225 | <0.0001 |
| Categorical variableb | ||||||||
| Female sex | 3.62 | <0.0001 | – | – | 3.51 | <0.0001 | – | – |
| Current smoking | 0.606 | <0.0001 | 0.745 | 0.0261 | 0.562 | <0.0001 | 0.681 | 0.0161 |
| Current alcohol | 0.568 | <0.0001 | 0.662 | <0.0001 | 0.597 | <0.0001 | 0.674 | <0.0001 |
| Self-reported fracture history | 1.93 | <0.0001 | 2.12 | <0.0001 | 1.86 | <0.0001 | 1.99 | <0.0001 |
| RF positive | 1.08 | 0.2111 | 1.01 | 0.841 | 1.11 | 0.1779 | 1.05 | 0.514 |
| Medication use | ||||||||
| MTX | 0.967 | 0.619 | 0.978 | 0.777 | 0.962 | 0.616 | 0.998 | 0.981 |
| bDMARDs | 1.01 | 0.842 | 0.947 | 0.448 | 0.946 | 0.488 | 0.897 | 0.179 |
| Glucocorticoid | 3.58 | <0.0001 | 3.58 | <0.0001 | 3.11 | <0.0001 | 2.99 | <0.0001 |
| Hypertension | 1.98 | <0.0001 | 2.46 | <0.0001 | 1.96 | <0.0001 | 2.33 | <0.0001 |
| Hyperlipidemia | 1.82 | <0.0001 | 1.92 | <0.0001 | 1.73 | <0.0001 | 1.80 | <0.0001 |
| Diabetes mellitus | 1.27 | 0.09122 | 1.80 | 0.000247 | 1.30 | 0.0469 | 1.76 | 0.00138 |
RA, rheumatoid arthritis; DAS, disease activity score; JHAQ-DI, Japanese Health Assessment Questionnaire-Disability Index; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; RF, rheumatoid factor; MTX, methotrexate; PSL, prednisolone; bDMARD, biologic disease-modifying antirheumatic drugs.
Spearman rank correlation for coefficient continuous variables.
Odds ratios from Fisher exact test of categorical variables.